Rare diseases
Investigational molecules
Locations
331 conditions with trials, the busiest first
872 trials across Europe, recruiting first
Study on Izokibep for Improving Symptoms in Patients with Active Psoriatic Arthritis
BulgariaStudy on the Effectiveness and Safety of Deucravacitinib for Patients with Active Systemic Lupus Erythematosus (SLE)
BulgariaStudy on the Effectiveness and Safety of Deucravacitinib for Patients with Active Systemic Lupus Erythematosus (SLE)
BulgariaStudy on the Effects of Filgotinib for Adults with Active Axial Spondyloarthritis
BelgiumStudy on Vixarelimab for Patients with Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease
BelgiumStudy on the Safety and Effectiveness of ESK-001 for Adults with Systemic Lupus Erythematosus
BulgariaStudy on the Effects of HZN-1116 for Patients with Sjögren’s Syndrome
AustriaStudy on the Effects and Safety of ODM-111 and Paracetamol for Chronic Knee Pain in Osteoarthritis Patients
CzechiaStudy on the Effectiveness and Safety of Bimekizumab and Risankizumab in Adults with Active Psoriatic Arthritis
BulgariaPharmacokinetic Study of Ritlecitinib Tosilate in Healthy Adults: Oral Solution, Short‑and Long‑Duration Capsules Fed vs Fasted – for ulcerative colitis
BelgiumPhase 2 Study of Daxdilimab with Prednisone in Adults with Inadequately Controlled Dermatomyositis or Anti‑Synthetase Inflammatory Myositis
CzechiaTulisokibart in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease
BelgiumThe therapies tested most often in Musculoskeletal and connective tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
